Grass Valley Radiation Oncology – Trademark Portfolio
Entity Type: 03
Grass Valley Radiation Oncology holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 3 are pending. Notable registered marks include CURERAYS, KEEP CANCER AWAY, and CURERAYS RADIATION MEDICINE. The owner is based in Grass Valley, CA.
300 Sierra College Drive, Ste. 150
Grass Valley, CA 95945
Showing of trademarks Trademarks
Trademark Classifications
Grass Valley Radiation Oncology's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Grass Valley Radiation Oncology have?
Grass Valley Radiation Oncology has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 pending.
What trademark classes does Grass Valley Radiation Oncology file in?
Grass Valley Radiation Oncology files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 10 (Medical Apparatus). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Grass Valley Radiation Oncology's most well-known trademarks?
Grass Valley Radiation Oncology's registered trademark portfolio includes well-known marks such as CURERAYS, KEEP CANCER AWAY, and CURERAYS RADIATION MEDICINE. These are among 3 currently registered trademarks in the portfolio.
What is Grass Valley Radiation Oncology's trademark registration success rate?
Grass Valley Radiation Oncology has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 3 applications are pending review.